Co-Diagnostics and Arabian Eagle Manufacturing have secured land in Sudair Industrial City, Saudi Arabia, to build a facility for manufacturing molecular diagnostic instruments and assays, supporting regional expansion in the Middle East and North Africa.
Read More
The rapid RT-PCR assay runs on the FINDER platform, establishing it as a molecular point-of-care platform with multifunctional capabilities.
Read More
The FDA has granted a CLIA waiver for FebriDx, enabling its use in over 300,000 U.S. point-of-care settings and potentially reaching 80 million patients annually, according to PHASE Scientific.
Read More
Roche has launched the cobas eplex RP3 panel for CE-markets, enabling simultaneous detection of up to 25 respiratory pathogens with customizable configurations, according to the company.
Read More
The WHO has issued its first recommendations for near-point-of-care molecular TB tests, tongue swab specimens, and sputum pooling, aiming to improve diagnostic access and efficiency, according to new consolidated TB guidelines.
Read More